Helicos China's GeneMind Biosciences Launches GenoCare 1600 Single-Molecule Sequencer Premium The sequencing-by-synthesis platform, using technology originally developed by Helicos, was approved by China's NMPA for noninvasive prenatal testing earlier this year. China NMPA Approves GeneMind GenoCare 1600 Sequencer for Noninvasive Prenatal Testing The sequencer, produced by Chinese sequencing tech company GeneMind Biosciences, is approved for noninvasive prenatal testing to detect common trisomies. SeqLL Withdraws Plans for $8M IPO The Massachusetts sequencing firm has been selling technology originally developed by Helicos BioSciences and planned to increase marketing with the IPO proceeds. True Bearing Readies RNA-Based Coronary Artery Disease Diagnostic for FDA Review, Launch Premium The company is collecting validation evidence it intends to submit to the FDA next year, which will also support launch of the test as an LDT. SeqLL Launches Early Access for Revamped Helicos Platform, Expands Service Business Premium The company plans to raise $25 million in a Series B financing round. It is also working on a two-color chemistry and aims to develop an instrument for clinical applications. Oct 27, 2015 China's Direct Genomics Unveils New Targeted NGS System Based on Helicos Tech for Clinical Use Premium Sep 30, 2014 SeqLL Plans to Revamp Helicos Technology Premium Sep 18, 2014 SeqLL Raises $1M to Enhance Service Offerings on Helicos Single-Molecule Platform Mar 11, 2014 Pathogen Search Underscores Need for Validation Steps When Sequencing Ancient Metagenomes Premium Nov 8, 2013 Fruit Fly Study Hints at RNA Editing Effect on Transposon-related Gene Silencing Jun 17, 2013 Bankruptcy Court OKs Helicos' IP License Deals with Illumina, Life Tech, Fluidigm, Complete Genomics; Negotiations Ongoing with Roche May 17, 2013 Helicos Seeks Bankruptcy Court Approval of Licensing Deals with Illumina, Life Tech, and Fluidigm Mar 11, 2013 Helicos Seeks Approval to Sell Assets, IP to Employee to Form New Company Dec 18, 2012 As Helicos Navigates Bankruptcy Process, Details Emerge on Disputes with Creditors and Customers Premium Nov 16, 2012 Helicos BioSciences Files for Chapter 11 Bankruptcy Protection Oct 2, 2012 Paired Ends: Carol Cox, Louise Mawhinney Premium Sep 11, 2012 Paired Ends: Ivan Trifunovich, Andrew Senyei, Paul Bianchi, and More Premium Sep 7, 2012 Helicos CEO Resigns Sep 4, 2012 Helicos Considers Next Moves as Remaining Patent in Illumina Suit Is Deemed Invalid Premium Sep 4, 2012 Paired Ends: Noubar Afeyan, Peter Barrett, Daniel O'Day, Pascal Soriot, Roland Diggelman Premium Aug 30, 2012 Federal Court Rules Helicos Patent Invalid; Company Reaches Payment Agreement with Lenders Aug 14, 2012 Helicos Q2 Sales Fall on Lower Grant, Service Revenues Aug 7, 2012 Helicos Licenses Patents to Intelligent Bio-Systems for $1.6M Jul 10, 2012 Helicos Drops Suit Against Life Tech, Leaving Illumina as Sole Defendant Premium May 14, 2012 Helicos Posts Sharp Drop in Q1 Revenues Load More Breaking News NanoString, A*Star, Next Level Genomics to Launch Spatial Biology Laboratory in Singapore FDA Approves Entrogen's RAS Mutation Detection Kit as CDx for Vectibix Cancer Predisposition Variants Increase Secondary Cancer Mortality Risk in Pediatric Survivors BostonGene, Johns Hopkins University Partner for Multiple Cancer Clinical Research Projects KromaTid, Noble Life Sciences Ink Distribution, OEM Agreement The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.